Full name
"KONFARM" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
55.10.Z - Hotels and similar accommodation establishments
56.10.A - Food service activities
56.21.Z - Occasional preparation and delivery of food for external clients (occasional catering)
56.29.Z - Food service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,6 | 0,2 | 0,4 | 101,1 |
EBITDA | 0,6 | 0,2 | 0,4 | 59,4 |
Short time liabilities | 0,5 | 1 | 0,8 | -19,8 |
Equity capital | 3 | 3,1 | 3,3 | 8,4 |
Operating profit (EBIT) | 0,6 | 0,2 | 0,4 | 54,6 |
Assets | 3,6 | 4,4 | 4,2 | -4,2 |
Net profit (loss) | 0,5 | 0,1 | 0,3 | 178,1 |
Cash | 1,3 | 1,2 | 1,9 | 61,4 |
Net income from sale | 11 | 12,4 | 13,8 | 11,2 |
Liabilities and provisions for liabilities | 0,6 | 1,3 | 0,9 | -33,7 |
Working assets | 2,7 | 3,7 | 3,6 | -3,3 |
Depreciation | 0 | 0 | 0 | 375,6 |
% | % | % | p.p. | |
Profitability of capital | 16,7 | 3 | 7,8 | 4,8 |
Equity capital to total assets | 82,8 | 70,1 | 79,3 | 9,2 |
Gross profit margin | 5,2 | 1,5 | 2,7 | 1,2 |
EBITDA Margin | 5,1 | 1,9 | 2,7 | 0,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 18 | 29 | 21 | -8 |
Current financial liquidity indicator | 4.934011459350586 | -0,3 | ||
Net dept to EBITDA | -2.020480155944824 | 8,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane